Functional reconstitution of ICln in lipid bilayers.
Reconstitution of purified ICln in lipid bilayer leads to functional ion channels showing varying rectification. The reconstituted single channels have a conductance of approximately equal to 3 pS and their open probability is sensitive to nucleoside analogues. Mutation of a putative nucleotide binding site identified at the predicted extracellular mouth of the ICln channel protein leads to the reduction of the nucleoside-analogue sensitivity. Reconstituted ICln channels can be permeated both by cations and anions. The relative permeability of cations over anions depends on the presence of calcium. In the presence of calcium reconstituted ICln channels are more permeable to bromide than chloride, and more permeable to potassium than sodium. Similarly in NIH3T3 fibroblasts, the relative permeability of cations over anions of swelling-dependent chloride channels depends on extracellular calcium. Site-directed mutagenesis revealed the calcium-binding site responsible for the shift of the selectivity from cations towards anions of reconstituted ICln channels. Additional indirect structural information has been obtained by mutating a histidine in the predicted pore region of ICln. This histidine seems to have access to the ion-conducting tunnel of the pore. Our experiments show that ICln can act as an ionic channel, which does not exclude additional functions of the protein in regulatory mechanisms of the cell. Since knocking down the ICln protein in fibroblasts and epithelial cells leads to an impaired regulatory volume decrease (RVD) after cytoplasmic swelling and reconstituted ICln channels show several biophysical features of ion channels activated after swelling, ICln is a molecular candidate for these channels.
Fürst
J
J
Department of Physiology, University of Innsbruck, Austria.
Bazzini
C
C
Jakab
M
M
Meyer
G
G
König
M
M
Gschwentner
M
M
Ritter
M
M
Schmarda
A
A
Bottà
G
G
Benz
R
R
Deetjen
P
P
Paulmichl
M
M
D016475:3T3 Cells; D000818:Animals; D001965:Bromides / Q000378:metabolism; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002460:Cell Line; D048429:Cell Size / Q000187:drug effects; D002614:Chelating Agents / Q000494:pharmacology; D002712:Chlorides / Q000378:metabolism; D004285:Dogs; D007473:Ion Channels / Q000037:antagonists & inhibitors / Q000378:metabolism*; D017136:Ion Transport / Q000187:drug effects; D008051:Lipid Bilayers / Q000378:metabolism*; D051379:Mice; D016297:Mutagenesis, Site-Directed; D009532:Nickel / Q000494:pharmacology; D009705:Nucleosides / Q000378:metabolism / Q000494:pharmacology; D009865:Oocytes / Q000166:cytology / Q000378:metabolism; D018408:Patch-Clamp Techniques; D011188:Potassium / Q000378:metabolism; D017434:Protein Structure, Tertiary; D011506:Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D013379:Substrate Specificity / Q000187:drug effects; D014162:Transfection; D029867:Xenopus Proteins; D014982:Xenopus laevis
D001965:Bromides; C498731:CLNS1A protein, Xenopus; D002614:Chelating Agents; D002712:Chlorides; C498728:Clns1a protein, mouse; D007473:Ion Channels; D008051:Lipid Bilayers; D009705:Nucleosides; D011506:Proteins; D029867:Xenopus Proteins; D009532:Nickel; D011188:Potassium; D002118:Calcium